关于克莱马斯在神经疾病中的治疗潜力的见解
Sufang Jiang1, Xueji Wang1, Tianyu Cao1
1Department of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Frontiers in molecular neuroscience
|October 16, 2023
概括
克莱马斯是一种抗组胺,在中枢神经系统 (CNS) 中表现出保护作用. 本综述强调了它通过作用于神经元和神经质来治疗各种中枢神经系统疾病的好处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 克莱马斯丁是一种FDA批准的抗组胺剂,可减少组胺素症状.
- 它穿过血脑屏障,影响中枢神经系统 (CNS) 的细胞.
- 有证据表明克莱马斯具有神经保护性质.
研究的目的:
- 审查克莱马斯在中枢神经系统疾病中的有益作用.
- 要突出克莱马斯在中枢神经系统中的细胞机制.
- 探索克莱马斯对神经元,神经质和特定细胞类型 (如寡细胞) 的影响.
主要方法:
- 关于克莱马斯丁和中枢神经系统疾病的研究文献综述.
- 对克莱马斯与中枢神经系统细胞相互作用的研究分析.
- 专注于寡基细胞原生细胞 (OPC),寡基细胞 (OL),微质细胞和神经元.
主要成果:
- 克莱马斯在一系列中枢神经系统疾病中表现出有益的影响.
- 它影响中枢神经系统的关键细胞参与者,包括OPC,OL,微质和神经元.
- 该化合物穿越血脑屏障的能力对其中枢神经系统作用至关重要.
结论:
- 克莱马斯对于各种中枢神经系统疾病具有治疗潜力.
- 了解它的细胞相互作用为神经保护提供了洞察力.
- 对克莱马斯机制的进一步研究可能会导致新的中枢神经系统治疗方法.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
132
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
132
Parkinson's Disease: Treatment
283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
698
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
698
Alzheimer's Disease: Treatment
211
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
211
Cholinergic Antagonists: Therapeutic Uses
758
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
758
Direct-Acting Cholinergic Agonists: Therapeutic Uses
772
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
772


